Q4 2023 Holdings
Filed 2024-02-14 | 89 holdings | $709.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Boston Scientific Corp(BSX) | COM | 101137107 | $37.7M | 652,803 | 5.3% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $35.5M | 161,539 | 5.0% |
| Cooper COS Inc | COM NEW | 216648402 | $28.5M | 75,183 | 4.0% |
| Dexcom Inc(DXCM) | COM | 252131107 | $28.0M | 225,615 | 3.9% |
| Tenet Healthcare Corp(THC) | COM NEW | 88033G407 | $27.0M | 356,806 | 3.8% |
| Cencora Inc(COR) | COM | 03073E105 | $21.1M | 102,891 | 3.0% |
| Inspire MED SYS Inc(INSP) | COM | 457730109 | $21.1M | 103,746 | 3.0% |
| Rxsight Inc(RXST) | COM | 78349D107 | $20.7M | 513,032 | 2.9% |
| Insulet Corp(PODD) | COM | 45784P101 | $19.2M | 88,675 | 2.7% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $18.5M | 140,116 | 2.6% |
| Amgen Inc(AMGN) | COM | 031162100 | $17.7M | 61,524 | 2.5% |
| Abbott Labs(ABT) | COM | 002824100 | $17.3M | 156,727 | 2.4% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $16.8M | 267,594 | 2.4% |
| Becton Dickinson & Co(BDX) | COM | 075887109 | $16.4M | 67,458 | 2.3% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $16.0M | 738,589 | 2.2% |
| Schrodinger Inc(SDGR) | COM | 80810D103 | $14.5M | 405,232 | 2.0% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $14.3M | 360,467 | 2.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $13.6M | 294,788 | 1.9% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $13.3M | 186,272 | 1.9% |
| Qiagen NV(QGEN) | SHS NEW | N72482123 | $10.9M | 250,000 | 1.5% |
| Kiniksa Pharmaceuticals LTD | COM CL A | G5269C101 | $10.8M | 615,693 | 1.5% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $10.7M | 211,400 | 1.5% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $10.0M | 504,742 | 1.4% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $9.3M | 168,262 | 1.3% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $9.2M | 1,018,812 | 1.3% |
| DAY One Biopharmaceuticals I(DAWN) | COM | 23954D109 | $9.1M | 625,749 | 1.3% |
| Mettler Toledo International(MTD) | COM | 592688105 | $9.1M | 7,500 | 1.3% |
| Mannkind Corp(MNKD) | COM NEW | 56400P706 | $9.1M | 2,498,624 | 1.3% |
| Deciphera Pharmaceuticals in(DCPHEUR) | COM | 24344T101 | $9.0M | 561,025 | 1.3% |
| Humana Inc(HUM) | COM | 444859102 | $8.3M | 18,081 | 1.2% |
| Castle Biosciences Inc(CSTL) | COM | 14843C105 | $7.7M | 357,156 | 1.1% |
| Cvrx Inc(CVRX) | COM | 126638105 | $7.5M | 240,000 | 1.1% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $7.1M | 651,625 | 1.0% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $6.9M | 167,001 | 1.0% |
| Silk RD MED Inc | COM | 82710M100 | $6.7M | 545,235 | 0.9% |
| Veracyte Inc(VCYT) | COM | 92337F107 | $6.5M | 237,316 | 0.9% |
| Haemonetics Corp Mass(HAE) | COM | 405024100 | $6.0M | 69,940 | 0.8% |
| Augmedix Inc(AUGX) | COM | 05105P107 | $5.9M | 1,015,814 | 0.8% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $5.7M | 312,889 | 0.8% |
| Cullinan Oncology Inc(CGEM) | COM | 230031106 | $5.4M | 529,877 | 0.8% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $5.4M | 92,871 | 0.8% |
| Thermo Fisher Scientific Inc(TMO) | COM | 883556102 | $5.3M | 10,000 | 0.7% |
| Sutro Biopharma Inc | COM | 869367102 | $5.2M | 1,202,431 | 0.7% |
| Bristol-Myers Squibb Co(BMY) | COM | 110122108 | $5.1M | 100,000 | 0.7% |
| Lantheus Hldgs Inc(LNTH) | COM | 516544103 | $5.0M | 80,000 | 0.7% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $5.0M | 82,009 | 0.7% |
| Performant Finl Corp(PFMTUSD) | COM | 71377E105 | $4.9M | 1,580,865 | 0.7% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $4.7M | 247,664 | 0.7% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $4.7M | 150,816 | 0.7% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $4.6M | 130,265 | 0.7% |